Next Article in Journal
The Enterotoxicity of Clostridium difficile Toxins
Previous Article in Journal
Effects of Ochratoxin A on Livestock Production
Article

Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen

1
Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37235, USA
2
Department of Pharmacology, Vanderbilt University, Nashville, TN 37235, USA
3
Department of Medicine, Vanderbilt University, Nashville, TN 37235, USA
*
Author to whom correspondence should be addressed.
Received: 14 May 2010 / Revised: 23 June 2010 / Accepted: 6 July 2010 / Published: 9 July 2010
The Clostridium perfringens epsilon toxin, a select agent, is responsible for a severe, often fatal enterotoxemia characterized by edema in the heart, lungs, kidney, and brain. The toxin is believed to be an oligomeric pore-forming toxin. Currently, there is no effective therapy for countering the cytotoxic activity of the toxin in exposed individuals. Using a robust cell-based high-throughput screening (HTS) assay, we screened a 151,616-compound library for the ability to inhibit e-toxin-induced cytotoxicity. Survival of MDCK cells exposed to the toxin was assessed by addition of resazurin to detect metabolic activity in surviving cells. The hit rate for this screen was 0.6%. Following a secondary screen of each hit in triplicate and assays to eliminate false positives, we focused on three structurally-distinct compounds: an N-cycloalkylbenzamide, a furo[2,3-b]quinoline, and a 6H-anthra[1,9-cd]isoxazol. None of the three compounds appeared to inhibit toxin binding to cells or the ability of the toxin to form oligomeric complexes. Additional assays demonstrated that two of the inhibitory compounds inhibited ε-toxin-induced permeabilization of MDCK cells to propidium iodide. Furthermore, the two compounds exhibited inhibitory effects on cells pre-treated with toxin. Structural analogs of one of the inhibitors identified through the high-throughput screen were analyzed and provided initial structure-activity data. These compounds should serve as the basis for further structure-activity refinement that may lead to the development of effective anti-ε-toxin therapeutics. View Full-Text
Keywords: bacterial toxins; Clostridium perfringens; cell membrane permeability; small molecule libraries; structure-activity relationship; drug evaluation; preclinical bacterial toxins; Clostridium perfringens; cell membrane permeability; small molecule libraries; structure-activity relationship; drug evaluation; preclinical
Show Figures

Graphical abstract

MDPI and ACS Style

Lewis, M.; Weaver, C.D.; McClain, M.S. Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen. Toxins 2010, 2, 1825-1847. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins2071825

AMA Style

Lewis M, Weaver CD, McClain MS. Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen. Toxins. 2010; 2(7):1825-1847. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins2071825

Chicago/Turabian Style

Lewis, Michelle, Charles David Weaver, and Mark S. McClain 2010. "Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen" Toxins 2, no. 7: 1825-1847. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins2071825

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop